Liliana Haversen

Goeteborg, O 41345, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Tunable Aromatic Sulfoxides and Sulfones as Cysteine-Targeting Warheads: Exploring the Structure-Reactivity Relationship.

Tunable Aromatic Sulfoxides and Sulfones as Cysteine-Targeting Warheads: Exploring the Structure-Reactivity Relationship.

Journal: Journal of medicinal chemistry

Published: March 09, 2026

Potent Fluorescent Probe for Target-Engagement Studies of Allosteric Pyruvate Kinase Modulators.

Potent Fluorescent Probe for Target-Engagement Studies of Allosteric Pyruvate Kinase Modulators.

Journal: Angewandte Chemie (International ed. in English)

Published: June 26, 2025

Fluorescent binding assay for allosteric ligands of liver pyruvate kinase.

Fluorescent binding assay for allosteric ligands of liver pyruvate kinase.

Journal: European journal of medicinal chemistry

Published: May 09, 2025

Design and application of a fluorescent probe for imaging of endogenous Bruton's tyrosine kinase with preserved enzymatic activity.

Design and application of a fluorescent probe for imaging of endogenous Bruton's tyrosine kinase with preserved enzymatic activity.

Journal: RSC chemical biology

Published: December 15, 2024

Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cells.

Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cells.

Journal: Clinical & translational immunology

Published: February 27, 2024

Sulfone-based human liver pyruvate kinase inhibitors - Design, synthesis and in vitro bioactivity.

Sulfone-based human liver pyruvate kinase inhibitors - Design, synthesis and in vitro bioactivity.

Journal: European journal of medicinal chemistry

Published: September 18, 2023

Exploration of Novel Urolithin C Derivatives as Non-Competitive Inhibitors of Liver Pyruvate Kinase.

Exploration of Novel Urolithin C Derivatives as Non-Competitive Inhibitors of Liver Pyruvate Kinase.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 02, 2023

Tuning liver pyruvate kinase activity up or down with a new class of allosteric modulators.

Tuning liver pyruvate kinase activity up or down with a new class of allosteric modulators.

Journal: European journal of medicinal chemistry

Published: December 30, 2022

Serendipitous Identification of a Covalent Activator of Liver Pyruvate Kinase.

Serendipitous Identification of a Covalent Activator of Liver Pyruvate Kinase.

Journal: Chembiochem : a European journal of chemical biology

Published: June 14, 2022

pH-Dependent Protonation of Histidine Residues Is Critical for Electrostatic Binding of Low-Density Lipoproteins to Human Coronary Arteries.

pH-Dependent Protonation of Histidine Residues Is Critical for Electrostatic Binding of Low-Density Lipoproteins to Human Coronary Arteries.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: June 02, 2022

Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase.

Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase.

Journal: European journal of medicinal chemistry

Published: February 03, 2022

Design and development of photoswitchable DFG-Out RET kinase inhibitors.

Design and development of photoswitchable DFG-Out RET kinase inhibitors.

Journal: European journal of medicinal chemistry

Published: October 30, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026